Dimethyl itaconate inhibits LPS-induced inflammatory release and apoptosis in alveolar type II epithelial and bronchial epithelial cells by activating pulmonary surfactant proteins A and D
CONCLUSION: The findings of the present study revealed that DMI inhibited LPS-induced inflammatory release and apoptosis in cells by targeting SIRT1 and then activating SP-A and SP-D. This novel insight into the pharmacological mechanism of DMI lays the foundation for its later use for alleviating lung injury.PMID:36335462 | DOI:10.15586/aei.v50i6.586
Source: Allergologia et Immunopathologia - Category: Allergy & Immunology Authors: Yun Shi Huai-Qing Yin Source Type: research
More News: Allergy & Immunology | Cytokine Therapy | Hormonal Therapy | Hormones | Stem Cell Therapy | Stem Cells | Study